Skip to main content
    B

    Baxter International Inc (BAX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $25.55
    -0.26 (-1.03%)

    Market Cap: $13.35B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Baxter International Inc (BAX) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Baxter International (BAX) trades at 13.2x trailing earnings and 1.1x sales. Its P/E of 13.2x is below its 5-year median of 13.5x. Its forward P/E is 12.2x. The median P/E across 11 similar companies is 20.7x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 8.2% higher over the next year. PEG is left out because the growth rate behind it, P/E divided by PEG, is under 2% a year.

    MultipleValue
    P/E (trailing)13.2x
    Forward P/E12.2x
    Price to sales1.1x
    Price to book2.0x
    EV/EBITDA19.5x
    Price to FCF11.6x
    EV/FCF17.4x
    PEGN/A
    FCF yield8.6%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 42.6% below 23.0x, its P/S is 63.3% below 3.0x and its P/B is 48.7% below 3.9x.

    MultipleCurrent5-year median10-year median
    P/E13.2x13.5x23.0x
    P/S1.1x2.0x3.0x
    P/B2.0x2.4x3.9x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 8.4x in 2025 to 26.0x in 2020. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$19.118.4x0.9x1.6x
    2024$29.1612.2x1.4x2.1x
    2023$38.6614.3x1.9x2.3x
    2022$50.9714.6x2.6x4.4x
    2021$85.8423.7x3.6x4.8x
    2020$80.2426.0x3.5x4.8x
    2019$83.6224.9x3.8x5.5x
    2018$65.8221.6x3.2x4.5x
    2017$64.6426.0x3.3x3.9x
    2016$44.3422.7x2.4x2.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About BAX

    What is BAX's forward P/E ratio?

    Baxter International has a forward P/E ratio of 12.2x.

    Is BAX stock overvalued?

    GNG's valuation label for BAX is Undervalued. Its P/E of 13.2x compares with a median of 20.7x across 11 similar companies.

    What is BAX's price to sales ratio?

    Baxter International has a price to sales ratio of 1.1x.

    What is Baxter International's average P/E ratio over 5 years?

    Baxter International's median P/E over the last 5 years is 13.5x, from 60 month-end values through Oct 2026.